Evidence map›Paper›PMID 25992652›Full record

ArticlePloS one2015

Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.

Bai-Wei Gu, Marisa Apicella, Jason Mills, Jian-Meng Fan, Dara A Reeves, Deborah French, Gregory M Podsakoff, Monica Bessler, Philip J Mason

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Ribosomes: from conserved origin to functional/medical mobility and heterogeneity.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  6. Article
  7. Roles of ribosomal RNA in health and disease.Frontiers in RNA research · 2023
    Article
  8. A Novel Variant and a Missense Variant Identified in theClinical, cosmetic and investigational dermatology · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Pseudouridylation defect due toProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Biology and clinical relevance of noncoding sno/scaRNAs.Trends in cardiovascular medicine · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Bai-Wei GuDepartment of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Marisa ApicellaDepartment of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Jason MillsDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Jian-Meng FanDepartment of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Dara A ReevesDepartment of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Deborah FrenchDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Gregory M PodsakoffDivision of Hematology, Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Monica BesslerDepartment of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Philip J MasonDepartment of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Children's Hospital of Philadelphia · US

Funding

Research BaseP30DK090969 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI CARROLL, MARTIN · 2010 to 2015
$5.7M
MOLECULAR STUDIES OF BONE MARROW FAILURER01CA105312 · NCI · WASHINGTON UNIVERSITY · PI BESSLER, MONICA · 2004 to 2014
$4.9M
THE PATHOGENESIS OF DYSKERATOSIS CONGENITAR01CA106995 · NCI · WASHINGTON UNIVERSITY · PI MASON, PHILIP J · 2005 to 2014
$3.0M
NCI NIH HHS 2R01 CA105312NCI NIH HHS 2R01CA106995NCI NIH HHS R01 CA105312NCI NIH HHS R01 CA106995NIDDK NIH HHS P30 DK090969
6 · The paper itself

Abstract

Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized by the presence of short telomeres at presentation. Mutations in ten different genes, whose products are involved in the telomere maintenance pathway, have been shown to cause DC. The X-linked form is the most common form of the disease and is caused by mutations in the gene DKC1, encoding the protein dyskerin. Dyskerin is required for the assembly and stability of telomerase and is also involved in ribosomal RNA (rRNA) processing where it converts specific uridines to pseudouridine. DC is thought to result from failure to maintain tissues, like blood, that are renewed by stem cell activity, but research into pathogenic mechanisms has been hampered by the difficulty of obtaining stem cells from patients. We reasoned that induced pluripotent stem (iPS) cells from X-linked DC patients may provide information about the mechanisms involved. Here we describe the production of iPS cells from DC patients with DKC1 mutations Q31E, A353V and ΔL37. In addition we constructed "corrected" lines with a copy of the wild type dyskerin cDNA expressed from the AAVS1 safe harbor locus. We show that in iPS cells with DKC1 mutations telomere maintenance is compromised with short telomere lengths and decreased telomerase activity. The degree to which telomere lengths are affected by expression of telomerase during reprograming, or with ectopic expression of wild type dyskerin, is variable. The recurrent mutation A353V shows the most severe effect on telomere maintenance. A353V cells but not Q31E or ΔL37 cells, are refractory to correction by expression of wild type DKC1 cDNA. Because dyskerin is involved in both telomere maintenance and ribosome biogenesis it has been postulated that defective ribosome biogenesis and translation may contribute to the disease phenotype. Evidence from mouse and zebra fish models has supported the involvement of ribosome biogenesis but primary cells from human patients have so far not shown defects in pseudouridylation or ribosomal RNA processing. None of the mutant iPS cells presented here show decreased pseudouridine levels in rRNA or defective rRNA processing suggesting telomere maintenance defects account for most of the phenotype of X-linked DC. Finally gene expression analysis of the iPS cells shows that WNT signaling is significantly decreased in all mutant cells, raising the possibility that defective WNT signaling may contribute to disease pathogenesis.

Indexed as

AnimalsCell Cycle ProteinsCells, CulturedDyskeratosis CongenitaFemaleGene Expression RegulationHumansInduced Pluripotent Stem CellsMaleMiceMutationNuclear ProteinsRibosomesTelomeraseTelomereWnt Signaling PathwayCell Cycle ProteinsDKC1 protein, humanNuclear ProteinsTelomerase

Identifiers

PMID25992652
PMCPMC4436374
OpenAlexW2177517278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.